Research ArticleArticle
The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH2-Terminal Structure
Mieke Gouwy, Sofie Struyf, Frank Mahieu, Willy Put, Paul Proost and Jo Van Damme
Molecular Pharmacology July 2002, 62 (1) 173-180; DOI: https://doi.org/10.1124/mol.62.1.173
Mieke Gouwy
Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium
Sofie Struyf
Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium
Frank Mahieu
Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium
Willy Put
Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium
Paul Proost
Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium
Jo Van Damme
Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH2-Terminal Structure
Mieke Gouwy, Sofie Struyf, Frank Mahieu, Willy Put, Paul Proost and Jo Van Damme
Molecular Pharmacology July 1, 2002, 62 (1) 173-180; DOI: https://doi.org/10.1124/mol.62.1.173
Research ArticleArticle
The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH2-Terminal Structure
Mieke Gouwy, Sofie Struyf, Frank Mahieu, Willy Put, Paul Proost and Jo Van Damme
Molecular Pharmacology July 1, 2002, 62 (1) 173-180; DOI: https://doi.org/10.1124/mol.62.1.173
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement